Home › Funds › REGENTS OF THE UNIVERSITY OF CALIFORNIA › BBOT
REGENTS OF THE UNIVERSITY OF CALIFORNIA position in BBOT
BRIDGEBIO ONCOLOGY THERAPEUT · Health Care
REGENTS OF THE UNIVERSITY OF CALIFORNIA reported holding 2,509,446 shares of BBOT (BRIDGEBIO ONCOLOGY THERAPEUT) in its Q3 2026 13F filing — a position valued at US$10.3M, representing 0.25% of its reported portfolio and ranking #7 among its reported holdings. REGENTS OF THE UNIVERSITY OF CALIFORNIA first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How REGENTS OF THE UNIVERSITY OF CALIFORNIA's BBOT position evolved
REGENTS OF THE UNIVERSITY OF CALIFORNIA first disclosed a stake in BBOT in Q3 2026 at 2,509,446 shares (US$10.3M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 2.51M | $10.29M | New |
About BBOT and 13F data
BBOT (BRIDGEBIO ONCOLOGY THERAPEUT) is a Health Care company. 81 other funds we track also report a position in BBOT — the largest reported positions include Cormorant Asset Management, LP (US$136.2M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$37.2M), Omega Fund Management, LLC (US$25.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BBOT
- Cormorant Asset Management, LP 17.88M sh · $136.23M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 4.89M sh · $37.23M · Q2 2026
- Omega Fund Management, LLC 3.29M sh · $25.07M · Q2 2026
- EcoR1 Capital, LLC 2.82M sh · $21.51M · Q2 2026
- Enavate Sciences GP, LLC 2.63M sh · $20.02M · Q2 2026
- Novo Holdings A/S 2.25M sh · $17.14M · Q2 2026
- Alphabet Inc. 2.82M sh · $11.57M · Q3 2026
- Opaleye Management Inc. 700.00K sh · $5.33M · Q2 2026
- Aisling Capital Management LP 1.02M sh · $4.14M · Q3 2026
- Catalio Capital Management, LP 318.41K sh · $2.43M · Q2 2026
- Casdin Capital 282.31K sh · $2.15M · Q2 2026
- Avidity Partners Management LP 43.85K sh · $334.16K · Q2 2026
More on REGENTS OF THE UNIVERSITY OF CALIFORNIA
FAQ
How long has REGENTS OF THE UNIVERSITY OF CALIFORNIA held BBOT?
REGENTS OF THE UNIVERSITY OF CALIFORNIA has disclosed BBOT holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is REGENTS OF THE UNIVERSITY OF CALIFORNIA's current position in BBOT?
As of Q3 2026, REGENTS OF THE UNIVERSITY OF CALIFORNIA holds 2.51M shares of BBOT (BRIDGEBIO ONCOLOGY THERAPEUT), valued at $10.29M, representing 0.25% of its reported portfolio and ranking #7.
Has REGENTS OF THE UNIVERSITY OF CALIFORNIA been buying or selling BBOT?
In the latest 13F filing (Q3 2026), REGENTS OF THE UNIVERSITY OF CALIFORNIA newly opened its position in BBOT.
Which other funds hold BBOT?
Other major institutional holders of BBOT include Cormorant Asset Management, LP, DEERFIELD MANAGEMENT COMPANY, L.P., Omega Fund Management, LLC, among 81 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.